Transcode Therapeutics, Inc. (RNAZ) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-52.59 | +96.1% |
| 2024 | $-1336.63 | +60.9% |
| 2023 | $-3419.01 | -215.8% |
| 2022 | $-1082.79 | -133577.8% |
| 2021 | $-0.81 | -58.8% |
| 2020 | $-0.51 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-52.59 | +96.1% |
| 2024 | $-1336.63 | +60.9% |
| 2023 | $-3419.01 | -215.8% |
| 2022 | $-1082.79 | -133577.8% |
| 2021 | $-0.81 | -58.8% |
| 2020 | $-0.51 | — |